Literature DB >> 15793885

Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux.

Carlo Calabrese1, Anna Fabbri, Mauro Bortolotti, Giovanna Cenacchi, Scialpi Carlo, Desiree Zahlane, Mario Miglioli, Giulio Di Febo.   

Abstract

AIM: To value whether omeprazole could induce the healing of DIS and regression of symptoms in patients with DGER.
METHODS: We enrolled 15 symptomatic patients with a pathological esophageal 24-h pH-metry and bilimetry. Patients underwent endoscopy and biopsies were taken from the distal esophagus. Specimens were analyzed at histology and transmission electron microscopy (TEM). Patients were treated with omeprazole 40 mg/d for 3 mo and then endoscopy with biopsies was repeated. Patients with persistent heartburn and/or with an incomplete recovery of DIS were treated for 3 more months and endoscopy with biopsies was performed.
RESULTS: Nine patients had a non-erosive reflux disease at endoscopy (NERD) while 6 had erosive esophagitis (ERD). At histology, of the 6 patients with erosive esophagitis, 5 had mild esophagitis and 1 moderate esophagitis. No patients with NERD showed histological signs of esophagitis. After 3 mo of therapy, 13/15 patients (86.7%, P<0.01) showed a complete recovery of DIS and disappearance of heartburn. Of the 2 patients treated for 3 more months, complete recovery of DIS and heartburn were achieved in one.
CONCLUSION: Three or 6 mo of omeprazole therapy led to a complete regression of the ultrastructural esophageal damage in 86.7% and in 93% of patients with DGER, NERD and ERD respectively. The ultrastructural recovery of the epithelium was accompanied by regression of heartburn in all cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793885      PMCID: PMC4305895          DOI: 10.3748/wjg.v11.i12.1876

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective.

Authors:  R C Orlando
Journal:  Am J Gastroenterol       Date:  1996-09       Impact factor: 10.864

2.  Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

Authors:  J P Galmiche; P Barthelemy; B Hamelin
Journal:  Aliment Pharmacol Ther       Date:  1997-08       Impact factor: 8.171

3.  Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.

Authors:  H P Festen; H A Tuynman; J Défize; G Pals; R R Frants; J P Straub; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1986-06       Impact factor: 3.199

4.  Histological consequences of gastroesophageal reflux in man.

Authors:  F Ismail-Beigi; P F Horton; C E Pope
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

5.  The role of acid and duodenal gastroesophageal reflux in symptomatic GERD.

Authors:  G H Koek; J Tack; D Sifrim; T Lerut; J Janssens
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

6.  Dilated intercellular spaces: a morphological feature of acid reflux--damaged human esophageal epithelium.

Authors:  N A Tobey; J L Carson; R A Alkiek; R C Orlando
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

7.  Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment.

Authors:  Carlo Calabrese; Mauro Bortolotti; Anna Fabbri; Alessandra Areni; Giovanna Cenacchi; Carlo Scialpi; Mario Miglioli; Giulio Di Febo
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

8.  Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.

Authors:  G H Koek; D Sifrim; T Lerut; J Janssens; J Tack
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

10.  Role of the components of the gastroduodenal contents in experimental acid esophagitis.

Authors:  K D Lillemoe; L F Johnson; J W Harmon
Journal:  Surgery       Date:  1982-08       Impact factor: 3.982

View more
  6 in total

1.  Factors influencing intercellular spaces in the rat esophageal epithelium.

Authors:  Dong-Hong Zhang; Li-Ya Zhou; Xiu-Yun Dong; Rong-Li Cui; Yan Xue; San-Ren Lin
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 2.  Biomarkers of Reflux Disease.

Authors:  Leila Kia; John E Pandolfino; Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

3.  Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole.

Authors:  Carlo Calabrese; Davide Treré; Giuseppina Liguori; Veronica Gabusi; Manuela Vici; Giovanna Cenacchi; Massimo Derenzini; Giulio Di Febo
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

4.  Is the Impedance Baseline Helpful in the Evaluation of Globus Patients?

Authors:  Yeon Joo Chun; Myung-Gyu Choi; Hyung Hun Kim; Yu Kyung Cho; AeKyeong Ku
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

5.  Variation of the intercellular space in the esophageal epithelium in response to hydrochloridric acid infusion in patients with erosive esophagitis.

Authors:  Ricardo Tedeschi Matos; Rodrigo Schuler Honório; Elia Garcia Caldini; Claudio Lyoiti Hashimoto; Marcelo Alves Ferreira; Tomás Navarro-Rodriguez
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

6.  Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease.

Authors:  Chanjuan Zhong; Liping Duan; Kun Wang; Zhijie Xu; Ying Ge; Changqing Yang; Yajing Han
Journal:  J Gastroenterol       Date:  2012-10-18       Impact factor: 7.527

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.